Complete but not partial thymectomy in early infancy reduces T-cell–mediated immune response: Three-year tracing study after pediatric cardiac surgery 

Slides:



Advertisements
Similar presentations
Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study 
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.
A wolf in sheep's clothing
David W. Barbara, MD, William J. Mauermann, MD, James R
Prediction of severe acute kidney injury after pediatric cardiac surgery with the use of novel biomarkers: A new trend in clinical research and risk stratification 
Ultrasound, endoscopy, and the recurrent nerve
Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery  Kazuto Yokoyama,
Management of immune dysfunction after adult cardiac surgery
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Intrinsic cardiac stem cells are essential for regeneration
Sequela-free long-term survival of a 65-year-old woman after 8 hours and 40 minutes of cardiac arrest from deep accidental hypothermia  Marie Meyer, MD,
The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.
Form ever follows function
William M. DeCampli, MD, PhD 
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Go on-pump or off-pump in diabetic patients?
Transcranial Doppler ultrasonography: A reliable method of monitoring pulsatile flow during cardiopulmonary bypass in infants and young children  Ashley.
Cutoff for high-sensitivity cardiac troponin T is not arbitrary but according to usual clinical practice  Hector Cubero-Gallego, MD, PhD, Maria Heredia,
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 
Hypogammaglobulinemia after cardiopulmonary bypass in infants
Gabriel Loor, MD, Liang Li, PhD, Joseph F
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
Conduit conundrum: If not two, why three?
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures 
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Cedric Manlhiot, PhD, Colleen.
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
A first start for lung transplantation?
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery  Torsten Doenst, MD, PhD,
Stephen R. Broderick, MD, MPHS 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Commentary: Faster recovery after complex neonatal cardiac surgery
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Should early extubation be the goal for children after congenital cardiac surgery?  Kevin C. Harris, MD, MHSc, Spencer Holowachuk, BHK, Sandy Pitfield,
Niv Ad, MD, Lawrence M. Wei, MD 
Left sinus of Valsalva aneurysm: Rare disease, rarer presentation
Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery  Christian.
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
A fate worse than death  Jennifer S. Lawton, MD 
Marc Licker, MD, John Diaper, RA 
The Ross procedure: Time to reevaluate the guidelines
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Sutureless valve implantation: Every detail counts
Jason J. Han, MD, Pavan Atluri, MD 
Early extubation after cardiac surgery: The evolution continues
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Commentary: “Isn't cardiac surgery a team sport?”
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
The continuing challenge of congenital heart disease in China
Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.
“The more things change…”: The challenges ahead
Apples remain apples NO matter what
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Did you like Terminator 3 better than Terminator 2
A good chimney requires a good sweep
How do we follow up our patients
Lessons learned from Melody valve retrieved at transplantation
Deciding how much to pay for effective care
Presentation transcript:

Complete but not partial thymectomy in early infancy reduces T-cell–mediated immune response: Three-year tracing study after pediatric cardiac surgery  Hirotsugu Kurobe, MD, PhD, Takashi Tominaga, MD, PhD, Mikio Sugano, MD, Yasunobu Hayabuchi, MD, PhD, Yoshiyasu Egawa, MD, PhD, Yousuke Takahama, PhD, Tetsuya Kitagawa, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 3, Pages 656-662.e2 (March 2013) DOI: 10.1016/j.jtcvs.2012.12.015 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Peripheral blood cell count after thymectomy. A and B, Three-year monitoring of peripheral blood cell count. Indicated cell populations (cell count per mm3) were measured before and 0.5 to 3 years after surgery. Numbers in top plot indicate the numbers of patients for measurements at individual time points. *P < .05. **P < .005. B, Data from subgroups of patients aged less than 20 days at the time of surgery (Figure E2). C and D, Numbers of CD4+CD25+Foxp3+ regulatory T cells (per mm3) in peripheral blood 3 years after surgery. Dots represent the results for individual patients, and bars indicate the means. Open circles indicate patients without CPB, and filled circles indicate patients with CPB. D, Data from subgroups of patients aged less than 20 days at the time of surgery (Figure E2). Patient identification numbers in (D) refer to the patient numbers indicated in Tables E1 and E2. CPB, Cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 656-662.e2DOI: (10.1016/j.jtcvs.2012.12.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 IgG responses to vaccinated viruses, PHA responses, and clinical courses. A and B, Titers of serum IgG antibody to the vaccinated measles and rubella viruses were measured 3 years after surgery. An IgG antibody titer that exceeded 4 units was clinically determined to be positive for the antibody. B, Data from subgroups of patients aged less than 20 days at the time of surgery. C and D, Isolated T cells were cultured in the presence or absence of PHA. Indicated are the values of PHA-induced stimulation index. Dots represent the results from individual patients, and bars indicate the means. Open circles indicate patients without CPB, and filled circles indicate patients with CPB. D, Data from subgroups of patients aged less than 20 days at the time of surgery. Patient identification numbers in (D) refer to the patient numbers indicated in Tables E1 and E2. CPB, Cardiopulmonary bypass; IgG, immunoglobulin G; n.s., not significant; PHA, phytohemagglutinin. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 656-662.e2DOI: (10.1016/j.jtcvs.2012.12.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Frequencies of outpatient consultation and hospitalization after thymectomy. A and B, Frequencies of outpatient consultation and hospitalization per year are plotted. Dots represent the results for individual patients, and bars indicate the means. Outpatient consultation and hospitalization represent emergency visits and do not include scheduled visits. B, Data from subgroups of patients aged less than 20 days at the time of surgery. Open circles indicate patients without CPB, and filled circles indicate patients with CPB. Patient identification numbers in (B) refer to the patient numbers indicated in Tables E1 and E2. CPB, Cardiopulmonary bypass; n.s., not significant. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 656-662.e2DOI: (10.1016/j.jtcvs.2012.12.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 Representative results for CD3+CD19− T cells and CD3−CD19+ B cells in the peripheral blood of individual patients (cell number per mm3). Patient numbers in this figure correspond to the patient numbers indicated in Tables E1 and E2. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 656-662.e2DOI: (10.1016/j.jtcvs.2012.12.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure E2 Age of patients at the time of surgery. Left: Comparison between groups P and C showing a significant difference in age. Right: Comparison among subgroups of patients aged less than 20 days at the time of surgery showing no significant difference in age. n.s., Not significant. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 656-662.e2DOI: (10.1016/j.jtcvs.2012.12.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions